Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study.

Add to Collection

2023 Aug Others A Rastogi, SA Kulkarni, SK Deshpande… - Advances in wound …, 2023 - liebertpub.com 105

Full Author : ['Rastogi, Ashu', 'Kulkarni, Sudhir A', 'Deshpande, Supreet K', 'Driver, Vickie', 'Barman, Hemanga', 'Bal, Arun', 'Deshmukh, Manisha', 'Nair, Harikrishna']
Journal Title : Advances in wound care
Chapter : Section1
Journal Year : 2023
Cited by : 1.0

We aimed to assess safety and dose-finding efficacy of esmolol hydrochloride (Galnobax) for healing of diabetic foot ulcer (DFU). This is phase 1/2 multicenter, randomized, double-blind vehicle-controlled study. Participants having diabetes and noninfecte..... Read More

Keywords : ["diabetic foot wound phase multicenter randomize doubleblind vehiclecontrolled parallelgroup study", "novel topical esmolol hydrochloride galnobax"]
PubMed Link : https://www.liebertpub.com/doi/abs/10.1089/wound.2022.0093
Google Scholar Link : https://scholar.google.com/scholar?cites=11731146321020965873&as_sdt=5,33&sciodt=0,33&hl=en&num=20

Have a Question?

Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study.